If you made any changes in Pure these will be visible here soon.

Personal profile

Awards

  • 2015: The Diabetes Association and Endocrine Society of Republic of China, Outstanding Paper Award
  • 2014 :Taipei Medical Center Diabetes Shared Care Medical Quality-2nd prize
  • 2013: Taipei Medical Center Diabetes Shared Care Medical Quality 2nd Prize
  • 2012: Taipei Medical Center Diabetes Shared Care Medical Quality 1st Prize
  • 2012: Taipei Medical University School of Medicine, Postgraduate Thesis Merit Award
  • 2012: Asian-Pacific Bayer Chinese Diabetes Forum 2012 Outstanding Poster Award
  • 2012: The Diabetes Association and Endocrine Society of Republic of China, Outstanding Paper Award

Experience

  • 2013: Associate Professor, School of Medicine, Taipei Medical University
  • 2009: Assistant Professor, School of Medicine, Taipei Medical University
  • 2003: Instructor, School of Medicine, Taipei Medical University
  • 1997-present: Consultant & Head, Diabetic Education Center, Wan Fang Hospital
  • 1996-present: Consultant Central Clinic Hospital
  • 1994-1996 Fellowship training Endocrinology and Metabolism, Taipei Veterans General Hospital
  • 1996-1997 Clinical Instructor, School of Medicine, National Defense Medical Center
  • 1996-2007, Visiting consultant, Taipei Veterans General Hospital 9
  • 1997-2000: Consultant, Central Health Insurance Bureau of Taipei Joint Outpatient Clinic
  • 1996-1999 Executive board, Taiwan Association of Diabetes Education
  • 2005-2017: Representative of Taiwan Association of Diabetes Education
  • 2011-2017: Representative of Society of Internal Medicine
  • 2012-2016: Executive board The Endocrine Society of Republic of China
  • 2009-2011: Board Committee National Conspiracy Agency, Ministry of the Interior, Military Services
  • 2013-2018: Board Committee, Taipei Military Services
  • 2012-present: Examiner OSCE Taiwan Institute of Medical Education

Research Interests

  • Clinical and basic research in Diabetes
  • Clinical and basic research on Endocrine diseases
  • Clinical research on new drugs development

Education

  • 2012, PhD (Graduate Institute of Clinical Medicine), Taipei Medical University
  • 1985, M.D. (School of Medicine) University of Santo Tomas
  • 1981, Bachelor (Science Accelerated) University of Santo Tomas

Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 8 Similar Profiles
Peroxisome Proliferator-Activated Receptors Medicine & Life Sciences
Cardiac Myocytes Medicine & Life Sciences
Diabetes Mellitus Medicine & Life Sciences
Diabetic Cardiomyopathies Medicine & Life Sciences
rosiglitazone Medicine & Life Sciences
Histone Deacetylases Medicine & Life Sciences
Calcium Medicine & Life Sciences
Patient Education Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2014 2019

Research Output 1997 2018

  • 519 Citations
  • 14 h-Index
  • 52 Article
  • 2 Conference contribution
  • 2 Review article

Activation of Class I histone deacetylases contributes to mitochondrial dysfunction in cardiomyocytes with altered complex activities

Lkhagva, B., Kao, Y. H., Lee, T. I., Lee, T. W., Cheng, W. L. & Chen, Y. J., May 1 2018, (Accepted/In press) In : Epigenetics. p. 1-10 10 p.

Research output: Contribution to journalArticle

Histone Deacetylases
Cardiac Myocytes
Tumor Necrosis Factor-alpha
Adenosine Triphosphate
Enzymes
4 Citations

Aging modulates the substrate and triggers remodeling in atrial fibrillation

Lin, Y. K., Chen, Y. A., Lee, T. I., Chen, Y. C., Chen, S. A. & Chen, Y. J., Jan 1 2018, In : Circulation Journal. 82, 5, p. 1237-1244 8 p.

Research output: Contribution to journalReview article

Atrial Fibrillation
Atrial Remodeling
Muscular Diseases
Comorbidity
Veins
Receptor, Fibroblast Growth Factor, Type 1
Histone Deacetylases
Calcitriol
Muscle Cells
Fibroblast Growth Factor 1

Difference between observed and predicted glycated hemoglobin at baseline and treatment response to vildagliptin-based dual oral therapy in patients with type 2 diabetes

Wang, J. S., Hung, Y. J., Lu, Y. C., Tsai, C. L., Yang, W. S., Lee, T. I., Hsiao, Y. C. & Sheu, W. H. H., Apr 1 2018, In : Diabetes Research and Clinical Practice. 138, p. 119-127 9 p.

Research output: Contribution to journalArticle

Glycosylated Hemoglobin A
Type 2 Diabetes Mellitus
Fasting
Glucose
Therapeutics

Histone deacetylase inhibition of cardiac autophagy in rats on a high-fat diet with low-dose streptozotocin-induced type 2 diabetes mellitus

Lee, T. I., Bai, K. J., Chen, Y. C., Lee, T. W., Chung, C. C., Tsai, W. C., Tsao, S. Y. & Kao, Y. H., Jan 1 2018, In : Molecular Medicine Reports. 17, 1, p. 594-601 8 p.

Research output: Contribution to journalArticle

Histone Deacetylases
Autophagy
High Fat Diet
Nutrition
Streptozocin